Calcific Aortic Valve Disease

0

Pipeline Programs↗

2

Active Trials↗

0

Companies Involved↗

Calcific Aortic Valve Disease is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

N/A

Attrition Rate

0/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

2

clinical trials

Not yet recruiting2 · 100%

Clinical Trials

Trial Activity

Folic Acid Supplementation in Calcific Aortic Valve Disease

Not yet recruiting·UUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology·Phase 2·NCT05861648·100 enrolled

Effects of Pioglitazone in Calcific Aortic Valve Disease

Not yet recruiting·UUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology·Phase 2·NCT05875675·100 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)